Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02602769 · ClinicalTrials.gov registry record

Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

A clinical trial of Childhood Obesity and Morbid Obesity, sponsored by Columbia University.

Recruiting
Registry status
12
Enrollment target
2
Study locations

NCT02602769: Recruiting study of Childhood Obesity and Morbid Obesity, sponsored by Columbia University.

NCT02602769 is a study of Childhood Obesity and Morbid Obesity that is actively recruiting participants, run by Columbia University. The registered enrollment target is 12 participants, below the 560-participant average among 43 other Childhood Obesity trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02602769, a study of Childhood Obesity and Morbid Obesity, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
12 participants
Enrollment target
2
Study locations

Study Summary

Rapid onset Obesity, Hypoventilation, Hypothalamic dysfunction and Autonomic Dysregulation (ROHHAD) is a syndrome named in 2007. The hallmark of the syndrome is the rapid onset obesity and dysregulation of central ventilation. There is little information about the metabolic changes that lead to the rapid onset obesity in these children. The investigators would like to study the metabolic phenotype of these children to understand the disturbances in energy balance that lead to the rapid onset obesity.

Primary Outcome

The investigators will perform whole transcriptome profiling of iPSC-derived hypothalamic neurons and compare the whole genome sequencing to identify the changes that may give rise to the disease.

Interventions

  • DIAGNOSTIC_TEST Transcriptome profiling

Study Locations (2)

New York

  • Boston Children's Hospital - Boston
  • Columbia University Irving Medical Center - New York

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2015-11
Est. Completion 2026-12
Columbia University

958 total trials

What NCT02602769 shows while recruiting

NCT02602769 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 560-participant average among 43 other Childhood Obesity trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Childhood Obesity appearing as the primary indexed condition, and to 1 intervention - of which Transcriptome profiling is the first listed.

NCT02602769 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT02602769 about?

NCT02602769 is a clinical study titled "Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome". Rapid onset Obesity, Hypoventilation, Hypothalamic dysfunction and Autonomic Dysregulation (ROHHAD) is a syndrome named in 2007. The hallmark of the syndrome is the rapid onset obesity and dysregulation of central ventilation. There is little information about the metabolic changes that lead to the ...

What is the current status of trial NCT02602769?

This trial is currently recruiting. The enrollment target is 12 participants. The study started on 2015-11. Estimated completion is 2026-12.

What conditions does trial NCT02602769 study?

This clinical trial studies the following conditions: Childhood Obesity, Morbid Obesity.

What interventions are being tested in trial NCT02602769?

The interventions under investigation include: Transcriptome profiling (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT02602769?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02602769 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02602769's enrollment target sits among peer trials

12 44th of 43 the lowest of 43 other Childhood Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Childhood Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

  • NCT03312556 · 12 participants · NA

    Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02602769, the US trial registry maintained by the National Library of Medicine. NCT02602769 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.